Atea (AVIR) Q2 2026 Earnings Call Transcript
Yahoo Finance · Aug 19, 2026 · Atea Pharmaceuticals Inc (AVIR)
HCV regimen met non-inferiority with 8-week dosing for non-cirrhotic patients.
Not investment advice. Headline and summary only, not a full reprint.